| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |